SCGB3A1 and breast carcinoma: To explore this connection further, we performed transcriptomic analysis on SUM159 breast cancer cells treated with activin B or SCGB3A1 and revealed their respective response signatures (Fig. 4d,e and Supplementary Tables 7 and 8).